Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Trending

Resveratrol lowered triglycerides in a meta-analysis of 337 people — but left total cholesterol, LDL, and HDL untouched.

This adds a small, positive signal to a body of evidence where two out of three prior studies found no effect, so the picture is still contested — not settled.

A meta-analysis of seven small randomized trials (337 people total) found that resveratrol significantly reduced triglyceride levels, but it had no effect on total cholesterol, LDL, or HDL. The authors suggest the triglyceride drop may stem from anti-inflammatory pathways rather than classic lipid regulation, but the overall evidence for resveratrol lowering triglycerides remains weak and mixed.

Where this fits in the evidence

Pillser has synthesized 4 studies on Resveratrol for Reduced Triglyceride Levels — overall evidence strength: Moderate.

Across 4 studies, 2 reported beneficial effects on triglycerides (moderate effect in one meta-analysis, small in another), while 2 found neutral effects (small effect size). The overall effect direction is mixed, with no clear predominant effect size (small to moderate). Evidence primarily derives from meta-analyses and systematic reviews in clinical populations, including postmenopausal women and patients with type 2 diabetes, but doses and forms were not consistently reported.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top